Search bioRxiv⌕ Search

Biology subjects

Matar, G. M.

Publications and source records attributed to Matar, G. M..

4 recordsLinked to original sources

First worldwide detection of blaIMP-15 in Stenotrophomonas maltophilia isolated from a patient in Lebanon.

Stenotrophomonas maltophilia is an intrinsically multi-drug resistant (MDR) bacterium initially found in the environment that is emerging worldwide. The rate of isolation from immunocompromised patients combined with limited treatment options make S. maltophilia a new concern in clinical settings. Here we report the first detection of the Metallo-{beta}-Lactamase (MBL) gene blaIMP-15 in S. maltophilia isolated from a patient in Lebanon. The isolate exhibited an extensively drug-resistant profile with high resistance to trimethoprim-sulfamethoxazole, levofloxacin, and minocycline considered by the Clinical and Laboratory Standards Institute (CLSI) as first-line antimicrobials used to treat such infections. Resistance to newly adopted anti-S. maltophilia agents was noted such as ceftazidime-avibactam. However, the isolate only showed susceptibility to cefiderocol and synergy was observed upon treatment with a combination of ceftazidime-avibactam and aztreonam by disk diffusion. Long-read and short-read whole-genome sequencing was performed and generated a hybrid assembly of 8 contigs. The isolate belonged to strain T50-20 and showed a novel sequence type. Moreover, several antimicrobial resistance genes conferring resistance to multiple antimicrobial classes were found. Particularly, blaIMP-15 was detected on insertion sequence IS6100 surrounded by transposition elements. Furthermore, the presence of the IMP gene was confirmed by polymerase chain reaction (PCR) followed by agarose gel electrophoresis and Sanger sequencing. This study highlights that the threat behind the blaIMP-15 gene is not only linked to the high resistance to Ceftazidime-avibactam in the S. maltophilia isolate but is also of concern due to its transmissibility to other pathogens, conferring alone an MDR profile.

microbiology↗

Isolation and Genomic Analysis of Escherichia Phage AUBRB02: Implications for Phage Therapy in Lebanon

We obtained a new and unique Escherichia phage, AUBRB02, from sewage water in Beirut, Lebanon, as part of this research. AUBRB02 has an incubation period of around 45 minutes, a lysis period of about 10 minutes, and a burst size of around 30 plaque-forming units per cell. The phage exhibited strong biological stability over a pH range of 5.0-9.0 and temperatures ranging from 4{degrees}C to 60{degrees}C. AUBRB02 was found to have a genome size of 166,871 base pairs and a G+C content of 35.47% using whole-genome sequencing. A comparative analysis revealed that AUBRB02, a newly found phage, shares 93% intergenomic similarity to closest relative in refseq. Functional annotation revealed the presence of 10 tRNA and 262 coding sequences, out of which 123 are categorized as putative proteins. These results indicate that AUBRB02 is a highly infectious virus that belongs to the Tequatrovirus genus. This study is significant reference information that can be used in the development of phage therapy. IMPORTANCEEscherichia coli, a gram-negative bacterium, is a widely distributed pathogen in the natural environment and a frequent cause of illnesses. The extensive utilization of antibiotics has resulted in a rise of clinically resistant strains, posing a substantial obstacle to antimicrobial therapy. This urgent circumstance highlights the necessity for antibiotic substitutes to combat E. coli infections. In this context, we introduce AUBRB02, a novel Escherichia phage isolated from an untreated sewage source in Beirut. Our findings indicate that AUBRB02 is highly lytic, stable against extreme culturing conditions, and has a biofilm elimination capability.

microbiology↗

An unusual two-strain cholera outbreak in Lebanon, 2022-2023: a genomic epidemiology study

BackgroundCholera is a bacterial infection caused by the ingestion of contaminated water or food. It principally affects the gastrointestinal system and spreads easily, causing outbreaks. The first case of cholera in this outbreak was detected in Lebanon in October 2022. The outbreak lasted three months, with 8,007 suspected cases (671 laboratory-confirmed) and 23 deaths. We characterised the Vibrio cholerae strain responsible for this cholera outbreak. MethodsIn total, 34 Vibrio cholerae isolates collected by random sampling of stools, water and plant samples throughout the outbreak and over the affected regions were studied by phenotypic methods and microbial genomics. FindingsAll isolates were V. cholerae O1, serotype Ogawa strains from wave 3 of the seventh pandemic El Tor (7PET) lineage. Phylogenomic analysis unexpectedly revealed the presence of two different 7PET strains, a highly unusual finding outside the Bay of Bengal, where several sublineages circulate together. The dominant strain had a narrow antibiotic resistance profile and was phylogenetically related to South Asian V. cholerae isolates. The second strain, which was found exclusively in South Lebanon and Beqaa, was resistant to multiple antibiotics, including macrolides, third-generation cephalosporins and cotrimoxazole. It belonged to the AFR13 sublineage and clustered with V. cholerae isolates collected in Yemen from 2016 to 2019. This second Lebanese strain also harboured the same multidrug-resistance (MDR) IncC-type plasmid found in Yemeni isolates from 2018. InterpretationThe 2022-2023 Lebanese cholera outbreak was caused by the simultaneous introduction of two different 7PET strains. The MDR strain was geographically limited, but the spread of this clone or the horizontal transfer of the MDR plasmid to more susceptible clones could affect epidemic cholera case management. Genomic surveillance is crucial to prevent further spread, and to ensure a prompt and effective response to outbreaks. FundingThe study was funded by the Centers for Disease Control (CDC) award number BAA 75D301-21-C-12132, a grant awarded to the American University of Beirut, WHO country office Lebanon, the Lebanese University, and Institut Pasteur. RESEARCH IN CONTEXT PANELO_ST_ABSEvidence before this studyC_ST_ABSWhole-genome sequencing (WGS) has greatly advanced our understanding and the characterisation of Vibrio cholerae outbreaks. However, few studies in the Middle East and North Africa (MENA) region have used this powerful technology. We searched PubMed for studies investigating the molecular epidemiology of V. cholerae by WGS in the MENA region, including Lebanon, with the terms "cholera*" AND "a country name of MENA countries" with no restrictions on language or date. The very small number of studies identified concerned Yemen and Algeria. All the outbreaks in the MENA region investigated to date and many others worldwide were caused by a single strain introduced once, contrasting with the endemic setting (the Bay of Bengal) in which several lineages circulate together. One manuscript addressing the history of cholera in Africa from a genomic perspective assigned three Lebanese strains from past outbreaks in 1970 and 1993 as O1 Ogawa isolates from waves 1 and 2 of the seventh pandemic lineage (7PET). Added value of the studyWe provide the first comprehensive overview of the molecular epidemiology of the V. cholerae strains responsible for the 2022-2023 Lebanese cholera outbreak. The use of WGS made it possible to distinguish clearly between two phylogenetically distant strains from genomic wave 3 of the 7PET lineage responsible for the Lebanese outbreak and to assign their putative origins to South Asia and Yemen. Based on their different susceptibility patterns (a predominant strain with a narrow resistance profile and a minor strain with an extended resistance profile), WGS excluded the hypothesis of the multidrug-resistant (MDR) minor strain emerging from the susceptible dominant strain through the acquisition of the MDR plasmid, instead clearly demonstrating the seeding of the outbreak by two different introductions. Implications of all available evidenceThis study demonstrates the importance of WGS associated with national surveillance for obtaining new insights and perspectives, modifying our perception of V. cholerae outbreak. This unexpected occurrence of a two-strain outbreak in a setting considered non-endemic for V. cholerae requires tight control by the local health authorities to prevent the sporadic introduction and spread of additional strains. Our findings raise the question of the extent to which the strains identified, particularly those from South Asia, spread in Iraq and Syria, neighbouring countries that declared cholera outbreaks before Lebanon. It is difficult to answer this question due to the lack of strains collected from these countries. Regional surveillance of the causal agent of cholera is therefore essential, to unravel transmission events and monitor the emergence of antimicrobial drug-resistant strains observed in many countries around the world.

microbiology↗

Genomic Surveillance of SARS CoV2 in COVID-19 vaccinated healthcare workers in Lebanon.

The emergence of SARS-CoV-2 variants including the Delta and Omicron along with waning of vaccine-induced immunity over time contributed to increased rates of breakthrough infection specifically among healthcare workers (HCWs). SARS-CoV-2 genomic surveillance is an important tool for timely detection and characterization of circulating variants as well as monitoring the emergence of new strains. Our study is the first national SARS-CoV-2 genomic surveillance among HCWs in Lebanon. We collected 250 samples from five hospitals across Lebanon between December 2021 and January 2022. We extracted viral RNA and performed whole genome sequencing using the Illumina NextSeq 500 platform. A total of 133 (57.1%) samples belonging to the Omicron (BA.1.1) sub-lineage were identified, as well as 44 (18.9%) samples belonging to the BA.1 sub-lineage, 28 (12%) belonging to the BA.2 sub-lineage, and only 15 (6.6%) samples belonging to the Delta variant sub-lineage B.1.617.2. These results show that Lebanon followed the global trend in terms of circulating SARS-CoV-2 variants with Delta rapidly replaced by the Omicron variant. This study underscores the importance of continuous genomic surveillance programs in Lebanon for the timely detection and characterization of circulating variants. The latter is critical to guide public health policy making and to timely implement public health interventions.

genomics↗